One miRNA identified across multiple cancers to inhibit PD-L1 expression is miR-200c which directly binds to the 3'UTR of PD-L1 in hepatocellular carcinoma (99), acute lymphoid leukemia (95), and NSCLC (100). Here, CD274 is linked to non-small cell lung carcinoma.